Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Clinical trial NCT04432454 · COMPLETED
Trial details
- NCT number
- NCT04432454
- Sponsor
- Sermonix Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-29
- Primary completion
- 2025-01-28
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.